CombiMatrix Launches Targeted Array for Prenatal Analysis
December 16, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Promotes Karine Hovanes, Ph.D., to Vice President of Scientific Advancement and Laboratory Director, and Trilochan Sahoo, M.D., to Vice President of Clinical Affairs and Director of Cytogenetics
November 19, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Enters IVF Market With Launch of CombiPGS(TM)
November 18, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Reports Third Quarter 2014 Financial and Operating Results
November 04, 2014 16:05 ET
|
CombiMatrix Corporation
– Reports Record Revenue, Cash Reimbursement and Test Volumes –
– Company to Host Conference Call and Webcast Today at 1:30 p.m. PST –
IRVINE, Calif., Nov. 4, 2014 (GLOBE...
CombiMatrix Corporation to Release Third Quarter Financial Results on November 4, 2014
October 28, 2014 16:05 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter 2014 financial results on Tuesday, November 4, 2014....
Data to be Presented at ASHG 2014 Show That Miscarriage Analysis by Chromosomal Microarray Yields a Successful Result in More Than 85% of Cases
October 14, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 14, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Reports Preliminary Growth in Prenatal Microarray Testing Volumes of 71% and 64% for the Third Quarter and Year-to-Date, Respectively
October 07, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental...
CombiMatrix Announces Payor Contract With Blue Cross Blue Shield of Illinois
September 08, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for pre- and post-natal developmental...
CombiMatrix Reports Second Quarter 2014 Financial and Operating Results
August 06, 2014 16:05 ET
|
CombiMatrix Corporation
- Reports Record Revenue and Test Volumes -
- Company to Host Conference Call and Webcast at 1:30 p.m. PDT, Today, August 6, 2014 -
IRVINE, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- CombiMatrix...
CombiMatrix's SNP-Based Miscarriage Analysis Test Granted Conditional Approval From New York State Department of Health
July 31, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer...